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In vertebrates, the establishment of the HSPC pool is a dynamic process that requires not only the HSPC fate specification from the haemogenic endothelium, but also their subsequent homing to distinct anatomic sites [2] [3] [4] [5] . In the zebrafish, HSPCs are initially formed in the ventral wall of the dorsal aorta in the aorta-gonad-mesonephros (AGM) region 3, 4 . The nascent HSPCs then migrate to the caudal haematopoietic tissue (CHT) and kidney marrow, which are the haematopoietic tissues equivalent to mammalian fetal liver and bone marrow, respectively, where the HSPCs undergo rapid expansion and differentiation to support larval and adult haematopoiesis 2, 10 . However, how HSPCs migrate to and finally colonize these tissues remains poorly understood.
To investigate these unknown mechanisms, we carried out a largescale forward genetics screen in zebrafish for mutants that display HSPC homing defects. The mutant line cas005 showed severe defects in definitive haematopoiesis, but normal primitive haematopoiesis and vascular morphogenesis (Extended Data Fig. 1a , b, e, g). Although the haemogenic endothelium in mut cas005 was intact, as revealed by whole-mount in situ hybridization (WISH) results of the nascent HSPC marker runx1 11 (a key transcription factor that regulates nascent HSPC emergence), the number of HSPCs in the mutant CHT was severely reduced (Extended Data Fig. 1c-e, g ), without increased HSPC apoptosis (Extended Data Fig. 1f ) compared to the wild-type CHT.
The genetic mutation was mapped to a loss-of-function mutation in the integrin alpha 4 (itga4) gene by positional cloning (Extended Data Fig. 2a-c) . Indeed, morpholino-mediated knockdown of itga4 expression (Extended Data Fig. 2e-g ) or a second zebrafish itga4 cas010 mutant generated by CRISPR-Cas9 12 (Extended Data Fig. 2b-d ) displayed similar phenotypes to that of mut cas005 , which was hence renamed as itga4 cas005 . WISH analysis showed that itga4 expression was enriched in both the AGM and the CHT in a runx1 11 -and myb 13 (another key transcription factor that regulates nascent HSPC migration into circulation)-dependent manner (Extended Data Fig. 2h ). Conversely, runx1 enhancer 14 -directed definitive HSPC re-expression of wild-type itga4 could rescue the itga4 mutant defects (Extended Data Fig. 2i-k) , indicating an HSPC cell-autonomous role of ITGA4.
The defective definitive haematopoiesis in zebrafish itga4 mutants is consistent with a previous report 15 . The VLA-4 integrin, composed of α 4 (itga4) and β 1 (itgb1) subunit, is predominantly expressed on HSPCs in mammals in early embryogenesis 16 . In mice, the α 4 integrin is essential for normal haematopoietic development in the fetal liver 15, 17 , and inhibition of α 4 could mobilize HSPCs from fetal livers by interfering with the homing and retention process 18, 19 . However, the precise mechanism by which ITGA4 regulates HSPC homing remains largely unknown.
To achieve real-time characterization of HSPC homing to, and retention in, the CHT, we took advantage of the transgenic line Tg(kdrl:Dendra2), in which the kdrl gene promoter drives the expression of the photoconvertible Dendra2 fluorescent protein in the entire vasculature. At 36 hours post-fertilization (h.p.f.), we converted the green fluorescence of Dendra2 + endothelial cells in the AGM to red (Extended Data Fig. 3a) . Consistent with previous reports 3, 4 , a substantial number of endothelial cells converted by endothelial-tohaematopoietic transition emerged from the aortic ventral wall into the sub-aortic space, subsequently entered the blood circulation, and finally colonized the CHT by 48-50 h.p.f. (Extended Data Fig. 3a, b) .
These photoconverted red Dendra2 + cells in the CHT were found to carry runx1 transcripts (Extended Data Fig. 3b ). In addition, the knockdown of runx1 or myb expression 13 significantly reduced the number of photoconverted red Dendra2 + cells in the CHT (Extended Data Fig. 3c, d ). These results confirmed that the photoconverted red Dendra2
+ cells homing to the CHT were nascent HSPCs. Thus, we were able to characterize the entire process and individual HSPC homing-retention events in the CHT. We found that the Letter reSeArCH lodgement of HSPCs initially took place at approximately 48-50 h.p.f., and the number of lodged HSPCs markedly increased over 24 h. However, in the itga4-mutant embryos, HSPC retention was barely detectable (Fig. 1a, c and Supplementary Video 1). More specifically, the average retention time of HSPCs in wild-type embryos is close to 30 min, whereas the HSPCs in the itga4 mutants went through the CHT quickly with very short retention times (average retention time of 4 min) (Fig. 1d , e, Extended Data Fig. 3e and Supplementary Video 2). The functional consequence of the disrupted HSPC retention was markedly reduced downstream haematopoietic lineages (Extended Data Figs. 1e, g, 2f, g ). We thus defined a successful HSPC retention event in the CHT as the lodgement of HSPCs for a period of more than 30 min (over 20% of HSPCs in the wild-type embryos, but less than 2% of HSPCs in the itga4 mutants).
It has been proposed that HSPCs reside in the anatomically defined niche, where they receive and integrate regulatory signals from the niche cells and extracellular matrices 6,7,20 for their expansion and differentiation. To understand the tendency of HSPC retention, we traced individual HSPCs and correlated their retention time with the dorsal-ventral relative location. This scatterplot analysis revealed that the longer HSPCs resided in the CHT, the greater was their tendency to reach the dorsal part of the caudal venous plexus (CVP) (Extended Data Fig. 4a ). Next, we analysed the frequency of HSPCs' appearance in the entire CHT over an 8-h time period. Unexpectedly, the retention of HSPCs was not evenly distributed in the dorsal part of the CVP, and instead the cells frequently occurred in several regions of the CHT in wild-type embryos. We referred to these regions as the retention 'hotspots' (Fig. 1f and Extended Data Fig. 4b, c) .
These retention hotspots are largely localized at the venous capillary confluence points that are connected to the CVP, in which the velocity of circulating photoconverted HSPCs is notably reduced (Extended Data Fig. 5a ). HSPCs that entered the CHT either from the intersegmental vessel (ISV) or from the CVP (Extended Data Fig. 5b -e and Supplementary Video 3) were sharply decelerated. We also found that most HSPCs that remained for more than 30 min were in the venous capillaries, which have similar diameters to that of HSPCs (Fig. 1b , Extended Data Fig. 6a -f, h, Supplementary Video 4). In the itga4 mutants, the retention hotspots were not evident (Extended Data  Fig. 4d ). However, there was no significant difference in the number, size or confluence points of the vascular architecture between wildtype embryos and itga4 mutants (Extended Data Fig. 6g, h ). These observations led us to hypothesize that other niche components might Letter reSeArCH be needed for HSPCs to enter the venous capillaries in an ITGA4-dependent manner.
Vascular cell adhesion molecule-1 (VCAM-1) is known as the major ligand for VLA-4 in mammalian cells 21, 22 . According to the ZFIN database (http://zfin.org/ZDB-GENE-070209-238), zebrafish vcam1 (also known as vcam1b) was specifically expressed in the cranial region, heart and the CHT at around 30 h.p.f. To evaluate the function of VCAM-1 in definitive haematopoiesis, we generated a vcam1 cas011 mutant (Extended Data Fig. 7a, b) . The mutants resembled the defects in homing and definitive haematopoiesis observed in the itga4 mutants (Fig. 2a, Extended Data Figs. 2f , g, 7c-f, Supplementary Video 5), indicating that the ITGA4-VCAM-1 axis has an evolutionarily conserved role in nascent HSPC homing and retention 16, 23 . Immunofluorescence staining showed that endogenous VCAM-1 was strongly expressed on cells that are mostly distributed at the dorsal CVP, where HSPCs show preferential lodgement (Fig. 2b) . In addition, VCAM-1 protein was also weakly expressed on some of the venous endothelial cells in the CHT (Extended Data Fig. 7g) . Importantly, the VCAM-1 + non-endothelial cells in the CHT were always next to HSPCs (Fig. 2c, Extended Data Fig. 7h ), which were neither previously described cxcl12a:DsRed + cells nor somite-derived stromal reticular cells 8, 9 (Extended Data Fig. 7i, j) . By contrast, we found that almost all the VCAM-1 + non-endothelial cells were GFP + in the macrophage-specific Tg(mpeg1:eGFP) transgenic line in the CHT (Fig. 2d) . Meanwhile, about 45% of mpeg1 + cells in the CHT are VCAM-1 + , and there are on average 13 VCAM-1 + macrophage-like cells per CHT (Extended Data Fig. 8d ) that express the macrophage markers mfap4, csf1ra and spi1a with high overlapping rates (Extended Data Fig. 8a and Supplementary Table 2 ). Thus, these VCAM-1 + non-endothelial cells in the CHT are likely to be a subtype of macrophages.
To characterize the potential function of these VCAM-1 Letter reSeArCH endothelium might also have a role by slowing down HSPCs to increase the chance for HSPC retention, even though the HSPC-CVP endothelium interaction is not absolutely required for HSPC retention.
To determine when the VCAM-1 + macrophages appear in the CHT, we performed a time-course analysis of VCAM-1 expression from 28 to 48 h.p.f. The immunofluorescence results demonstrated that the VCAM-1 + macrophages first appeared in the CHT at 32 h.p.f. (Fig. 3a) . The VCAM-1 + macrophages in the CHT were absent in the vcam1 cas011 mutants and independent of HSPC deficiency in either itga4 cas005 or runx1 w84x mutants at 54 h.p.f. (Fig. 3b) . Because the VCAM-1 + macrophages are present in the niche before the appearance of aorta-derived definitive HSPCs, these macrophages probably arise from the primitive macrophage lineage at this time point. We labelled the primitive macrophages by applying photoconversion on the Tg(mpeg1:Gal4,UAS:Kaede) line, and found that some macrophages from the rostral blood island 25 at 18 h.p.f. migrated to the CHT, and were VCAM-1 + (Extended Data Fig. 8h ). To characterize the behaviour and function of the VCAM-1 + macrophages in live animals further, we labelled VCAM-1 + macrophages with an anti-VCAM-1 647 antibody. The live imaging showed a nearly identical cell distribution pattern to that revealed by anti-VCAM-1 immunofluorescence (Extended Data Fig. 9a ). Live staining with the antibody remained stable for at least 8 h after intravascular antibody injection, without affecting definitive haematopoiesis, as demonstrated by quantitative myb WISH analysis (Extended Data Fig. 9b-d) .
Notably, these VCAM-1 + macrophages slowly patrolled on the inner sides, especially the dorsal CVP (Fig. 3c, Extended Data Fig. 9e , Supplementary Video 7). HSPCs, entering from either the ISV or the CVP into the CHT, always pass by the capillary confluence point, which leads to frequent interactions of HSPCs with the VCAM-1
After quantitative analysis of more than 100 VCAM-1 + macrophage-HSPC interactions and subsequent events (Fig. 4a, Supplementary  Table 3 ), we found that, on average, each interaction lasted approximately 30 min. About 60% of the HSPCs left the CHT through the venous plexus without retention (6-30 min), whereas around 40% of HSPCs could remain in the CHT for more than 30 min.
Among these lodged HSPCs, about 75% interacted with VCAM-1 + macrophages at the entrance of dorsal venous capillaries. With the guidance of VCAM-1 + macrophages, 20% could finally enter the venous capillaries and remained for more than 120 min. We defined this as 'type I' retention (Fig. 4a, Extended Data Fig. 9f, Supplementary  Video 8) . Conversely, 25% of the lodged HSPCs interacted with VCAM-1 + macrophages within the CVP, and then 6.25% were surrounded by an 'endothelial pocket' 14 structure, leading to the 'type II' retention (Fig. 4a, b, Extended Data Fig. 9f, Supplementary Video 9) . HSPCs that successfully interacted with VCAM-1 + macrophages (for more than 30 min) but failed to be guided into the vascular niche (55% as pre-type I and 18.75% as pre-type II retention) were termed 'type 0' retention. Notably, HSPCs have an increased chance of interacting with VCAM-1 + macrophages at venous capillary confluence points connected to the CVP where dorsal venous capillaries are also distributed and the hotspots of HSPCs retention were observed (Fig. 1f) .
In itga4 cas010 mutants, HSPCs encountered but did not interact with VCAM-1 + macrophages. They could not roll inside the vasculature, enter venous capillaries or be enveloped by endothelium. Instead, the HSPCs went quickly through the CHT (Extended Data Fig. 9g and Supplementary Video 10). Thus, the interaction mediated by ITGA4 and VCAM-1 has an essential role in HSPC homing and retention in the niche. Together with the feature that VCAM-1 + macrophages patrol at the dorsal CVP, we named these VCAM-1 + macrophages 'usher' cells. In addition, HSPCs retention in vcam1 cas011 mutants with macrophage-specific vcam1 re-expression restored the occurrence of type II retention, indicating that the loss of vascular VCAM-1 is not sufficient to disrupt the vascular 'cuddling' structure (Extended Data  Fig. 9h) .
In this study, we mainly focused on the period of 48-60 h.p.f. at the initiation of HSPC homing because current imaging technology and transgenic lines do not allow the symmetry division to be distinguished from the asymmetry one, although most of the HSPC division in the CHT occurred in the vascular niche (66% in type I, 30% in type II retention). Morphology-based asymmetry division of HSPCs was previously reported in the vascular cuddling structure 14 ; however, lineagespecific reporter lines with rapid responses are required in future studies to understand how the dynamic HSPC-niche interaction is coordinated with HSPC division.
We show that the behaviour of usher cells correlates with the retention of HSPCs in the CHT. It has been reported that macrophages promote the retention of HSPCs 26, 27 . Data Fig. 1e, g ). Future studies are warranted to investigate these important questions.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0709-7. 36 and Tg(mpeg1:eGFP) 37 were described previously. Genetic mapping and mutation identification of zebrafish cas005 mutant. The mut 005 line was identified in a large-scale N-ethyl-N-nitrosourea (ENU) -mutagenized F 2 family screen based on the myb expression phenotype of 5 days postfertilization (d.p.f.) zebrafish embryos. The ENU screen and positional cloning were performed as described previously 38 . The mutation was mapped to chromosome 9 by bulk segregation analysis with sequence length polymorphism (SSLP) markers 39 . Fine mapping was carried out to narrow down the genetic interval, and the mutation was finally flanked by two SSLP markers, z8363 and zK165L22. The cDNAs of candidate genes in the range were cloned and sequenced from siblings and mutants, and the putative mutation was confirmed by sequencing genomic DNA of individual mutant embryos. All primers used for this study are provided in Supplementary Table 1 . Plasmid construction. The zebrafish vcam1 (also known as vcam1b, accession number: ZDB-GENE-070209-238) was cloned and inserted into the Tol2 backbone between the UAS promoter and polyA. The runx1 +23 enhancer followed by P2A and in-frame mCherry was cloned into the Tol2 backbone, and the zebrafish itga4 (accession number: ZDB-GENE-110411-108) was amplified and inserted between the runx1 enhancer and P2A.The sequences of vcam1 and itga4 were verified by sequencing. The runx1 +23 enhancer 14 and UAS promoter 40 were cloned as previously reported. Microinjection and CRISPR-Cas9 mutagenesis. Morpholino oligonucleotides were designed and purchased from Gene Tools. The morpholino oligonucleotides used in this study give the same phenotypes as mutants. The itga4, runx1 41 , myb 13 and vcam1 morpholino oligonucleotides were injected into one-cell-stage embryos as previously described 42 . Transient transgenic constructs within Tol2 vectors (40 pg) were microinjected into one-cell-stage embryos with Tol2 transposase mRNA (40 pg) 43 . For CRISPR-Cas9-mediated generation of zebrafish mutants (itga4 cas010 and vcam1 cas011 ), guide RNAs (RNAs) were designed to target genes according to methods previously described 44 . The zebrafish codon-optimized Cas9 mRNA was synthesized from the pCS2-nCas9n plasmid (Addgene, plasmid47929) 12 and gRNAs were in vitro synthesized using the MAXIscript T7 kit (Ambion). The gRNAs (100 pg) were microinjected into one-cell-stage embryos with Cas9 mRNA (300 pg). Conventional WISH, FISH and RNA scope in situ analysis. The myb 45 , scl 46 , gata1 46 , pu.1 46 , kdrl 45 , runx1 47 , hbae1.1 45 , mpx 45 , lyz 45 , itga4, mfap4 48 and csf1ra 48 probes were transcribed in vitro by T3 or T7 polymerase (Ambion) with Digoxigenin RNA Labelling Mix (Roche). Conventional and fluorescence whole-mount in situ hybridization (WISH and FISH) was described previously 49 . The penetrance of the indicated phenotype is shown in the bottom right of each panel (Extended Data Figs. 1a-e, g, 2d , e, h, 7d-f and 9d) and the embryos were genotyped after WISH and before phenotypic analysis (Extended Data Figs. 2d , j, k, 7d-f, 8e and 9b). Images of conventional WISH were mounted in 4% methylcellulose and captured by Olympus SZX16 microscope with Olympus DP80 CCD. In FISH and immunofluorescence double-staining, embryos were stained with cy3 or cy5 (TSA system, Perkin Elmer), followed by immunofluorescence, and then imaged by Zeiss LSM880 confocal microscope. RNA scope was conducted with probe runx1 (P/N: 433351, ACDBio) and negative control probe (REF: 320871, ACDBio). RNA scope procedure was performed as previously described 50 , and imaged by Olympus FV1000 Fluoview scanning confocal microscope. A list of oligonucleotides used to amplify these probes is provided in Supplementary Table 1 . Immunofluorescence staining and usher cell live immunolabelling. Immunofluorescence staining was performed as previously described 51 , with mouse anti-DsRed (Abcam), mouse anti-eGFP (Abmart), rabbit anti-VCAM-1 antibody (immunized by 180-300 amino acids of zebrafish VCAM-1 protein, Abclonal), AF488/546/647-conjugated secondary antibody (Life Technologies) and TUNEL assay kit (Roche). Images were collected using Olympus FV1000 Fluoview scanning confocal, Zeiss LSM710 confocal and Zeiss LSM880 confocal microscope and the embryos were genotyped following imaging analysis (Fig. 3b and Extended Data Fig. 8d ). For live labelling of usher cells, VCAM-1 antibody (Abclonal) was conjugated with Alexa Fluor 647 dye and purified by Microscale Protein Labelling Kit (Invitrogen, A30009). Each embryo was injected 1 nl (0.4 ng) at the common cardinal vein into the circulation at 50 h.p.f. In vivo monitoring started from 2 h after injection and this live labelling is stable for more than 8 h 52 . Time-lapse intravital imaging was acquired by Zeiss LSM880 confocal microscope.
Inducible macrophage-specific cell depletion. As previously reported, MTZmediated cell depletion was performed on Tg(mpeg1:GAL4,UAS:NfsB-mCherry, kdrl:Dendra2) 34, 53 transgenic zebrafish embryos. Embryos from 24 to 60 h.p.f. were treated with freshly prepared 10 mM MTZ (Sigma) in 0.2% DMSO (dimethylsulfoxide) solution protected from light until the evaluation finished, then rinsed with embryo water three times.
Confocal microscope photoconversion and time-lapse live imaging analysis.
The photoconversion of irreversible monomeric green-to-red fluorescent protein Dendra2 54,55 expressed following specific promoter was conducted with a 405-nm laser for 30 s by an Olympus FV1000 Fluoview scanning confocal microscope. For the HSPC labelling system, the ventral endothelium of dorsal aorta (between somites 8 and 17) of Tg(kdrl:Dendra2) embryos was exposed to a beam of 405 nm ultraviolet (UV) laser light under a confocal microscope at 30-36 h.p.f. without affecting the normal endothelial-to-haematopoietic transition process, compared with that in untreated embryos 4 . The efficiency of cell labelling was confirmed under fluorescent microscope 8 h after photoconversion. The zebrafish with precise and bright photoconverted Dendra2 (red) cells were selected for further analysis. For the macrophage labelling system, the rostral blood island of Tg(mpeg1:Gal4,UAS:Kaede) zebrafish embryos was photoconverted at 18 h.p.f., followed by anti-VCAM-1 647 injection at 50 h.p.f., and imaging at 52 h.p.f. using Zeiss LSM880 confocal microscope.
For time-lapse imaging, embryos were anaesthetized with 0.03% Tricaine (Sigma), and mounted in 1.5% low melting point agarose in a 60-mm dish. The embryos were scanned at 28.5 °C under an Olympus FV1000 Fluoview scanning confocal microscope with 20× water immersion objective, z-stalks were acquired with a step size of 3 μm within an interval of 3 min over several hours. To observe more details between HSPCs and vascular niche, images were collected using a Zeiss LSM880 confocal by 40× water immersion objective; z-stalks were acquired with a size of 3 μm for over 8 h. The Zeiss LSM880 confocal allowed imaging of several embryos within a 2-5-min interval using a moving XY stage, as well as acquisition of z-stacks through the tissue in multiple channels. Note that 10 h is the maximum experimental duration of live-imaging analysis without phototoxicity. The embryos were genotyped following live-imaging analysis (Fig. 1a, c-e, 2a , e-g and Extended Data Figs. 3e, 4d, e, 6g, h, 7c, 8f, g, 9a, e, g, h) .
Imaging data processing and rendering was performed in FV10-ASW 3.0 Viewer (Olympus), ZEN 2.1 (ZEISS), Imaris (Bitplane) and ImageJ (NIH). The retention time and location information that each HSPC appears in the CHT was exported by Imaris 'Spots' module and programmed by Python into retention heatmap (https:// pypi.python.org/pypi/pyheatmap). The velocity of photoconverted HSPCs in the CHT was measured with the axial line scanning (ALS) as previously described [56] [57] [58] . Zeiss LSM880 equipped with Airyscan function was applied to capture highresolution fluorescent images, followed with 3D reconstruction by Materialise software (including Mimics Medical and 3-matic Medical). Statistical analysis. All statistical analysis was performed using Graphpad Prism 7 software using the two-tailed Student's t-test. Centre values denote the mean, and error values denote s.e.m. (Fig. 1c and Extended Data Figs. 1f, 2f, 3d, 6h,  8c, d, 9f) . The biologically independent sample size (n) was shown in the relevant figure panel (Fig. 1c and Extended Data Figs. 1f, 2f , j, 3d, 6h, 8c-e, 9b, f, h). All experiments in this study were repeated independently at least three times. For representative images, we have performed imaging on 5-10 embryos per independent experiments and repeated at least three times independently to find the most representative images (Figs. 1a, 2b-e, 3a-c, 4 and Extended Data Figs. 2k, 3e,  5a, c, d, 6e-g, 7c, g-j, 8a, c, g, h, 9a, c, e, g ). The graphs in Fig. 1d and Extended Data Fig. 8f show individual values in three embryos per group separately. In Fig. 1f and Extended Data Fig. 4b -e, imaging was performed on one embryo per independent experiment, repeated three times independently, and three images were chosen for the analysis. ****P < 0.0001. No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
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Sample size
No statistical methods were used to predetermine sample sizes. Sample sizes were predetermined on the basis of published studies. All experiments in this study were repeated for at least three times. Number of zebrafish embryos in live imaging were determined by the balance of imaging speed and statistical request. Number of embryos for WISH or IF were maximum with evenly staining.
Data exclusions Data analysis in this study was performed on original data directly, without any subjective exclusion.
Replication
All experiments in this study were repeated for at least three times, with same experimental protocol, followed by same statistical analysis. All attempts at replication were successful and identical.
Randomization The experimental animals were grouped based on the genotype, but allocated randomly for further analysis without subjective judgment.
Blinding
The investigators were blinded to the genotype of the embryos during phenotypic analysis and the embryos were genotyped after specific analysis.
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Laboratory animals
The Tubingen and WIK genetic background zebrafish strains were used in this study. 4-6 month old zebrafish were used to produce embryos (no sex-decision) for all experiments.
Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve samples collected from the field.
